A chemical approach to the construction of multimeric protein assemblies  by Muir, Tom W
WAYS & MEANS
A chemical approach to the construction of multimeric
protein assemblies
Structure 15 July 1995, 3:649-652
Despite the huge contributions made by synthetic chem-
istry to the construction of peptides and their analogs [1],
the world of proteins has proved somewhat less accessible
to chemical synthesis. While it was natural to assume that
the phenomenal success of peptide chemistry would lead
directly to the total synthesis of proteins, this has not
turned out to be the case. Indeed, it is now clear that the
chemical strategies originally developed for the synthesis
of peptides cannot be simply extended to the construc-
tion of proteins [2]. With a few notable exceptions, it has
been impracticable to synthesize proteins either by step-
wise solid-phase peptide synthesis (SPPS) or by classical
solution-based methods [2]. Recent years, however, have
seen the emergence of novel synthetic protein chemistries
that promise to redress the earlier shortcomings of organic
chemistry in the study of proteins and protein assemblies.
The conceptual breakthrough at the heart of these inno-
vative chemical ligation approaches is the simple realization
that a synthetic protein need not solely contain amide
linkages within its polypeptide backbone. All chemical
ligation strategies rely on highly selective reactions
between synthetic peptide 'synthons' (reactive intermedi-
ates), each bearing uniquely and mutually reactive groups.
The chemoselectivity of these ligation reactions means
that fully unprotected peptide segments can be used,
thereby overcoming the solubility and characterization
problems often associated with classical, convergent, solu-
tion-based approaches using protected peptide fragments.
Principles of chemical ligation
The large size of typical proteins generally prohibits, for
mainly statistical reasons, their direct chemical synthesis by
stepwise SPPS [2]. This constraint clearly suggests the use
of a convergent synthetic strategy involving the individual
construction of synthetically accessible peptide fragments,
followed by their assembly to afford the target protein
sequence. Classical fragment-condensation approaches of
this type have always been faithful to the view that the
amide bond is sacrosanct and hence indispensable. The
chemist's intransigence over the peptide bond has been a
serious handicap, as direct formation of an amide bond
between two peptide segments requires the use of varying
levels of side-chain protection [3-5]. Side-chain protec-
tion creates its own set of problems, as protected peptide
fragments have very limited solubility and are thus diffi-
cult both to purify and to covalently characterize.
Enzymatic coupling procedures, involving the use of
reverse proteolysis, in principle negate the need for side-
chain protection of peptide fragments and are thus
extremely attractive. Although this article will focus pri-
marily on chemical ligation approaches, it is important to
mention the significant progress in the area of enzyme-
driven ligation achieved by specific genetic engineering
of the serine protease subtilisin [6]. A double mutant
form of the enzyme, dubbed subtiligase, functions as an
effective acyl transferase and, importantly, has vastly
reduced proteolytic activity compared with the wild-type
enzyme. Mutation of the active-site serine to a cysteine
results in efficient acylation of the enzyme by peptides
esterified at their C terminus with a glycolate-phenyl-
alanine amide group [7]. A second active-site mutation
relieves steric crowding, allowing subsequent deacylation
of the enzyme-peptide thioester intermediate by the
N terminus of a second peptide fragment. The utility of
subtiligase-catalyzed ligation is illustrated by the total
synthesis of a ribonuclease A analog from six synthetic
peptide segments [7]. Incorporation of the unnatural
amino acid 4-fluorohistidine within the active site of the
enzyme allowed specific mechanistic questions to be
addressed in a precise way.
In contrast to enzymatic procedures, the recently intro-
duced chemical ligation strategies essentially bypass the
problems inherent to classical convergent approaches
altogether. This is achieved by simply looking beyond the
central reaction of peptide chemistry, namely the amina-
tion of activated carboxylates. Accordingly, chemical liga-
tion strategies utilize alternative organic reactions all of
which, at least initially, generate non-amide linkages
between the peptides being joined together (Fig. 1).
Thioester [8,9] and hydrazone [10] forming reactions
were among the first to be described, but have since been
joined by oxime [11], thioether [12,13] and thiozolidine
[14] based approaches (see Table 1).
A feature common to all chemical ligation strategies is the
selective nucleophilicity of the attacking species under the
optimum ligation conditions, typically neutral pH and
below. For example, the nucleophilic thioacid group will
react with appropriate electrophiles at pH 3 and above,
whereas all naturally occurring side-chain nucleophiles
(-SH, -NH2, -OH) require a substantially elevated pH
before they are in a reactive deprotonated form. This pro-
vides a unique window of reactivity in which only the
desired ligation reaction can take place, allowing both pep-
tide building blocks to be fully unprotected. As with their
enzyme-driven counterparts, the chemical ligation tech-
niques can be performed in aqueous media, but have the
added advantage of being tolerant to organic solvents [12]
and to solubilizing agents such as urea and guanidine [8].
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Fig. 1. Principle of chemical ligation.
The protein sequence is divided into two
or more approximately equal-sized pep-
tide fragments (typically around 50
residues). Each peptide building block is
then assembled by SPPS (although in
some cases recombinant peptide frag-
ments can be used [10,11]) and unique
functional groups are incorporated at
their N or C termini. These groups are
chosen to be mutually reactive under
pH conditions in which all other poten-
tially reactive side-chain functionalities
are chemically inert (see Table 1 for
groups and conditions). Following purifi-
cation, the completely unprotected pep-
tide building blocks are simply mixed
together in aqueous buffer systems. Sol-
ubilizing agents such as urea and guani-
dine can be used to increase reactant
concentrations, thereby improving the
kinetics of the ligation reaction. Follow-
ing reaction, a non-amide covalent link-
age is produced, at least initially, at the
ligation site.
An important extension of the chemical ligation
approach has recently been described [15], which makes
deliberate use of the remarkable intramolecular acylating
power of the thioester functionality [16]. Referred to as
native chemical ligation, the method utilizes a chemo-
selective reaction cascade that results in the straight-
forward generation of proteins with native backbone
structures from fully unprotected peptide building blocks
[15]. Reaction of an unprotected synthetic peptide-ox-
thioester with another unprotected peptide segment
containing an N-terminal cysteine residue gives a
thioester-linked intermediate as the initial covalent prod-
uct. Without change in the reaction conditions, this
intermediate undergoes spontaneous intramolecular
reaction to form a native peptide bond at the ligation
site. Accordingly, the target full-length polypeptide is
obtained in the desired final form without further
manipulation. Native chemical ligation can be per-
formed in the presence of all the functionalities com-
monly found in proteins, including free cysteine
sulfhydryls. This is illustrated by the successful synthesis
of interleukin-8, a 72 amino acid cytokine containing
four cysteine residues which form two functionally
critical disulfide bonds [15].
The assembly of unprotected peptide building blocks
into larger macromolecules need not involve the genera-
tion of covalent linkages using enzymes or selective
chemistries. Transition metal ions can be regarded as liga-
tion templates around which peptide ligands can be
assembled in a controlled way. Metal coordination chem-
istry has been successfully used to construct a hetero-
dinuclear three-helix-bundle metalloprotein containing
both Ru2+ and Cu2 + ions coordinated regioselectively to
three unprotected synthetic peptides [17]. Incorporation
of bipyridyl ligands at the N terminus and histidine lig-
ands at the C terminus of each peptide resulted in the
self-assembly of the expected complex in the presence of
the metal ions. Innovative approaches of this type
demonstrate how the principles of macromolecular
recognition can be exploited to allow the synthesis of
artificial protein assemblies.
Table 1. Current published chemical ligation techniques.
Ligation Nucleophilic Electrophilic group Ligation Proteins constructed
chemistry group conditions
Thioester Thioacid Bromoacetyl pH 3-7 HIV-1 protease [81,
Fibronectin type 3 module [9]
Thioether Thiol Bromoacetyl [12], maleimide [13] pH 6-8 Integrin domain [12]
Hydrazone Hydrazide Glyoxyl pH 4.6 Granulocyte colony-stimulating
factor [10]
Oxime Amino-oxy Levulinic acid [181, glyoxyl [11] pH 4.6 c-Myc-Max [18]
Thiozolidine Cysteine Aldehyde pH 3-5 NA
Amide Cysteine Thioester pH 5-8 Interleukin-8 1151
NA, not applicable - construction of an intact protein has not yet been described.
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New vistas in protein chemistry
Chemical and enzymatic ligation approaches provide a
general route to the synthesis of proteins whose primary
structure is not restricted to the genetic code. Thus,
one can replace key residues in a protein with unnatural
amino acids whose chemical or structural properties can
be tailored to probe specific aspects of function. In
addition, isotopically labeled amino acids can be incor-
porated at one or more positions within the primary
structure of the protein, thereby allowing highly
focused structural studies of the molecule using tech-
niques such as multidimensional NMR spectroscopy.
This new-found freedom will certainly afford expanded
opportunities in established areas of protein chemistry
such as structure-function related studies. However,
simple amino acid substitutions of this type represent
only the most elementary application of these enabling
technologies. Chemical ligation, in particular, has the
potential to make significant contributions in areas of
biology that are currently completely inaccessible to
researchers. Indeed, it is in the creation of pragmatic
new chemistry-driven strategies for the study of com-
plex biological systems that chemical ligation may be of
most value.
Chemical ligation is already finding a growing applica-
tion in the construction of covalently tethered protein
complexes designed to mimic or artificially recreate a
naturally occurring multiprotein complex. Chemically
stabilized protein molecules of this type are of genuine
importance, as non-covalent protein complexes are fre-
quently difficult to isolate from natural sources and are
often problematic to study in vitro. The artificial protein
assemblies illustrated in Figure 2 utilize both non-native
topology and non-amide bonding in their design, and
were intended to mimic a naturally occurring' system. In
the first example, the functionally critical cytoplasmic
domain of the integrin albb33 is modeled using a specifi-
cally designed synthetic protein hybrid [12]. Integrins are
members of a heterodimeric transmembrane receptor
superfamily, which also includes the cytokine and
immunoglobulin-like receptor families. Generation of
soluble truncated versions of these receptors for structural
studies is complicated by the non-covalent nature of the
subunit association; in the case of aIIb3 the individual
truncated a and 3 cytoplasmic tails will not associate to
form a functional complex. The synthetic model protein
was therefore designed to be highly soluble, allowing
structural analysis, and to contain structural elements
which would promote the association of the two cyto-
plasmic tails. This was achieved by covalently linking
both cytoplasmic tails via a parallel amphiphilic helical
coiled-coil, incorporated to mimic the membrane-span-
ning domain of the integrin and to act as a topological
constraint, fixing the tails in a parallel and proximal ori-
entation (Fig. 2a). The 126 amino acid soluble model
protein contains two C termini and was readily synthe-
sized from two peptide building blocks using a thioether-
based ligation strategy. Structural studies suggest that the
cytoplasmic tails within the model protein interact
Fig. 2. Synthetic proteins of non-linear architecture produced by
chemical ligation. Both molecules are color coded to indicate
the peptide fragments from which they were constructed.
(a) Soluble model of the cytoplasmic domain of the integrin
llb[ 3. The molecule contains two C termini and was constructedfrom the unprotected peptides, Cys-helix-allb (50 residues) and
BrAc-helix-3 3 (76 residues; BrAc=bromoacetyl), via a thioether-
forming ligation strategy [121. (b) Covalently linked c-Myc-Max
heterodimer (b, basic region; H, helix) constructed from four
peptide fragments (30-50 residues long) by convergent chemical
ligation [181. The individual c-Myc and Max subunits were first
constructed using the thioester approach, and subsequently
linked together using a second oxime-forming ligation chemistry
(see Table 1 for details on each chemistry). The two ligation
chemistries are mutually exclusive, allowing fully unprotected
peptides to be used throughout the assembly.
through a defined tertiary structure [12] and that this
may represent a biologically relevant conformation
(unpublished data).
In the second example, a unique transcription factor pro-
tein, c-Myc-Max, was chemically synthesized from four
peptide building blocks using a modular chemical liga-
tion strategy [18]. Non-covalent heterodimers of the
c-Myc and Max DNA-binding domains, which consist
of a basic region followed by a helix-loop-helix and then
a leucine zipper, are believed to be functionally impor-
tant transcription factors in vivo, but it has not been pos-
sible to make the heterodimer by means of standard
recombinant DNA technology. Thioester-forming liga-
tion reactions were initially used to assemble the individ-
ual c-Myc and Max domains, which were then stitched
together in a regioselective manner using an oxime-based
ligation approach. The resulting covalently linked 20 kDa
c-Myc-Max heterodimer contained two N termini
(Fig. 2b) and was found to bind promoter DNA in a
sequence-specific manner.
The two examples outlined above demonstrate that
chemical ligation provides the means to generate artificial
versions of protein complexes, which allow the biochem-
ical and structural properties of the system to be evalu-
ated, often for the first time. This unique access to
systems of unnatural topology in principle allows large
multisubunit protein complexes to be dissected into
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functionally discrete modules, permitting the biology
and structure of each to be studied. Thus, the continuing
integration of chemistry and biology through techniques
such as chemical ligation is likely to have a huge impact
on both established and embryonic areas of study in both
parent fields.
Conclusions
Chemical and enzymatic ligation techniques make possi-
ble the total synthesis of proteins and protein-like assem-
blies. Although a number of highly effective ligation
techniques already exist (Table 1), it seems likely that
many other chemical strategies will become available by
exploiting the reactions of organic chemistry and the
principles of bio-inorganic chemistry. Armed with these
powerful new tools, the synthetic protein chemist will
have straightforward access to an as yet uncharted world
of unnatural protein architectures and functions.
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